Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSN for Age-related Macular Degeneration
NCT07121127Phase 1Not yet recruiting
- Start
- Jul 2026
- Primary completion
- Aug 2029
01
Overview
Phase 1, randomised trial (2 arms). Primary endpoint: Best Corrected Visual Acuity at Day 14. Planned start Jul 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07121127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07121127.